CureVac N.V. (CVAC)

CureVac Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	510.51	535.18	53.76	67.42	102.99	48.87
Revenue Growth (YoY)	675.15%	895.54%	-20.26%	-34.54%	110.74%	180.61%
Cost of Revenue	26.31	105.63	116.21	158.97	215.27	14.17
Gross Profit	484.2	429.55	-62.45	-91.55	-112.28	34.7
Selling, General & Admin	81.34	74.34	95.74	107.07	102.26	54.29
Research & Development	169.94	153.03	115.72	62.55	815.91	113.81
Other Operating Expenses	-3.96	-7.6	-7.8	-36.66	-0.1	0.15
Operating Expenses	247.3	219.77	203.67	132.96	918.07	168.25
Operating Income	236.9	209.78	-266.12	-224.51	-1,030	-133.55
Interest Expense	-0.4	-	-	-2.3	-6.79	-22.1
Interest & Investment Income	11.8	12.36	2.02	15.41	0.08	2.07
Currency Exchange Gain (Loss)	0.84	0.84	-1.21	0.87	6.15	-
Other Non Operating Income (Expenses)	-0	-	13.43	-13.68	0.32	-
EBT Excluding Unusual Items	249.14	222.98	-251.88	-224.21	-1,031	-153.58
Merger & Restructuring Charges	-32.1	-32.1	-	-	-	-
Asset Writedown	3.35	-	-8.09	-24.95	-22.81	-
Other Unusual Items	-	-	-	-	640.9	23.74
Pretax Income	220.39	190.88	-259.97	-249.16	-412.5	-129.85
Income Tax Expense	26.75	28.7	0.2	-0.13	-0.78	-0.73
Net Income	193.64	162.19	-260.17	-249.03	-411.72	-129.12
Net Income to Common	193.64	162.19	-260.17	-249.03	-411.72	-129.12
Shares Outstanding (Basic)	225	224	221	189	186	132
Shares Outstanding (Diluted)	225	224	221	189	186	132
Shares Change (YoY)	0.24%	1.57%	16.84%	1.65%	40.71%	36.72%
EPS (Basic)	0.86	0.72	-1.18	-1.32	-2.21	-0.98
EPS (Diluted)	0.86	0.72	-1.18	-1.32	-2.21	-0.98
Free Cash Flow	197.04	87.54	-320.21	-374.2	-857.35	486.07
Free Cash Flow Per Share	0.88	0.39	-1.45	-1.98	-4.61	3.68
Gross Margin	94.85%	80.26%	-116.17%	-135.79%	-109.02%	71.00%
Operating Margin	46.40%	39.20%	-495.04%	-333.00%	-1000.44%	-273.27%
Profit Margin	37.93%	30.30%	-483.96%	-369.37%	-399.76%	-264.21%
Free Cash Flow Margin	38.60%	16.36%	-595.64%	-555.03%	-832.46%	994.61%
EBITDA	248.67	222.56	-249.33	-205.82	-1,020	-123.1
EBITDA Margin	48.71%	41.59%	-	-	-	-251.88%
D&A For EBITDA	11.77	12.78	16.79	18.69	10.31	10.46
EBIT	236.9	209.78	-266.12	-224.51	-1,030	-133.55
EBIT Margin	46.40%	39.20%	-	-	-	-273.27%
Effective Tax Rate	12.14%	15.03%	-	-	-	-

Updated Aug 15, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q